Article
Developments in the Treatment of Leber Hereditary Optic Neuropathy.
Current neurology and neuroscience reports - 1 Dec 2022
Chen Benson S, Yu-Wai-Man Patrick, Newman Nancy J
Abstract excerpt
PURPOSEOF REVIEW: To outline the current landscape of treatments for Leber hereditary optic neuropathy (LHON) along the therapeutic delivery pipeline, exploring the mechanisms of action and evidence for these therapeutic approaches. RECENT FINDINGS: Treatments for LHON can be broadly classified as either mutation-specific or mutation-independent. Mutation-specific therapies aim to correct the underlying mutation...
Topics
- Humans
- Optic Atrophy, Hereditary, Leber
- DNA, Mitochondrial
- Retinal Ganglion Cells
- Mitochondria
- Mutation
